← Insider Monitor
MACROGENICS INC logo
MGNX

MACROGENICS INC

Nasdaq · Pharmaceutical Preparations

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

MacroGenics is a biopharmaceutical company that develops antibody-based therapeutics for cancer treatment, using proprietary technology platforms to engineer bispecific antibodies and other immune-targeting molecules. Its pipeline includes margetuximab and other product candidates in various stages of clinical development, often advanced through partnerships with larger pharmaceutical companies.

Industry
Pharmaceutical Preparations
Headquarters
Rockville, MD
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Peters Jeffrey StuartSenior VP, GC, and SecretarySell$129KAug 19, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for MGNX.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable MGNX activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.